vs
Carter Bankshares, Inc.（CARE）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是Carter Bankshares, Inc.的1.8倍（$69.8M vs $39.8M），RIGEL PHARMACEUTICALS INC同比增速更快（21.2% vs 15.4%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 9.1%）
卡特银行股份有限公司是美国区域性银行控股企业，旗下运营卡特银行与信托机构，提供零售及商业银行服务，包含存款账户、个人及商业贷款、财富管理等产品，主要服务弗吉尼亚州和北卡罗来纳州的本地居民及中小商业客户。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
CARE vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.8倍
$39.8M
营收增速更快
RIGL
高出5.8%
15.4%
两年增速更快
RIGL
近两年复合增速
9.1%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $39.8M | $69.8M |
| 净利润 | — | $268.1M |
| 毛利率 | — | 91.5% |
| 营业利润率 | 27.8% | 33.2% |
| 净利率 | — | 384.0% |
| 营收同比 | 15.4% | 21.2% |
| 净利润同比 | — | 1769.2% |
| 每股收益（稀释后） | $0.38 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CARERIGL
| Q4 25 | $39.8M | $69.8M | ||
| Q3 25 | $39.1M | $69.5M | ||
| Q2 25 | $37.3M | $101.7M | ||
| Q1 25 | $37.0M | $53.3M | ||
| Q4 24 | $34.5M | $57.6M | ||
| Q3 24 | $34.2M | $55.3M | ||
| Q2 24 | $33.6M | $36.8M | ||
| Q1 24 | $33.5M | $29.5M |
净利润CARERIGL
| Q4 25 | — | $268.1M | ||
| Q3 25 | $5.4M | $27.9M | ||
| Q2 25 | $8.5M | $59.6M | ||
| Q1 25 | $9.0M | $11.4M | ||
| Q4 24 | — | $14.3M | ||
| Q3 24 | $5.6M | $12.4M | ||
| Q2 24 | $4.8M | $-1.0M | ||
| Q1 24 | $5.8M | $-8.2M |
毛利率CARERIGL
| Q4 25 | — | 91.5% | ||
| Q3 25 | — | 93.2% | ||
| Q2 25 | — | 95.6% | ||
| Q1 25 | — | 91.7% | ||
| Q4 24 | — | 89.9% | ||
| Q3 24 | — | 85.5% | ||
| Q2 24 | — | 92.4% | ||
| Q1 24 | — | 93.1% |
营业利润率CARERIGL
| Q4 25 | 27.8% | 33.2% | ||
| Q3 25 | 18.3% | 40.9% | ||
| Q2 25 | 28.5% | 60.1% | ||
| Q1 25 | 30.1% | 23.9% | ||
| Q4 24 | 31.0% | 28.9% | ||
| Q3 24 | 20.5% | 25.4% | ||
| Q2 24 | 17.6% | 1.2% | ||
| Q1 24 | 21.6% | -23.6% |
净利率CARERIGL
| Q4 25 | — | 384.0% | ||
| Q3 25 | 13.9% | 40.2% | ||
| Q2 25 | 22.8% | 58.6% | ||
| Q1 25 | 24.2% | 21.5% | ||
| Q4 24 | — | 24.9% | ||
| Q3 24 | 16.4% | 22.5% | ||
| Q2 24 | 14.3% | -2.8% | ||
| Q1 24 | 17.4% | -27.9% |
每股收益（稀释后）CARERIGL
| Q4 25 | $0.38 | $14.11 | ||
| Q3 25 | $0.24 | $1.46 | ||
| Q2 25 | $0.37 | $3.28 | ||
| Q1 25 | $0.39 | $0.63 | ||
| Q4 24 | $0.36 | $0.82 | ||
| Q3 24 | $0.24 | $0.70 | ||
| Q2 24 | $0.21 | $-0.06 | ||
| Q1 24 | $0.25 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | — | $155.0M |
| 总债务越低越好 | — | $52.5M |
| 股东权益账面价值 | $419.7M | $391.5M |
| 总资产 | $4.9B | $513.6M |
| 负债/权益比越低杠杆越低 | — | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资CARERIGL
| Q4 25 | — | $155.0M | ||
| Q3 25 | — | $137.1M | ||
| Q2 25 | — | $108.4M | ||
| Q1 25 | — | $77.1M | ||
| Q4 24 | — | $77.3M | ||
| Q3 24 | — | $61.1M | ||
| Q2 24 | — | $49.1M | ||
| Q1 24 | — | $49.5M |
总债务CARERIGL
| Q4 25 | — | $52.5M | ||
| Q3 25 | — | $60.0M | ||
| Q2 25 | — | $60.0M | ||
| Q1 25 | — | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益CARERIGL
| Q4 25 | $419.7M | $391.5M | ||
| Q3 25 | $412.8M | $117.6M | ||
| Q2 25 | $405.6M | $81.9M | ||
| Q1 25 | $401.8M | $18.6M | ||
| Q4 24 | $384.3M | $3.3M | ||
| Q3 24 | $386.8M | $-14.6M | ||
| Q2 24 | $364.4M | $-29.9M | ||
| Q1 24 | $359.1M | $-31.7M |
总资产CARERIGL
| Q4 25 | $4.9B | $513.6M | ||
| Q3 25 | $4.8B | $242.5M | ||
| Q2 25 | $4.8B | $206.7M | ||
| Q1 25 | $4.7B | $176.0M | ||
| Q4 24 | $4.7B | $164.0M | ||
| Q3 24 | $4.6B | $139.4M | ||
| Q2 24 | $4.5B | $128.4M | ||
| Q1 24 | $4.6B | $126.5M |
负债/权益比CARERIGL
| Q4 25 | — | 0.13× | ||
| Q3 25 | — | 0.51× | ||
| Q2 25 | — | 0.73× | ||
| Q1 25 | — | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $39.9M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $31.8M | — |
| 自由现金流率自由现金流/营收 | 79.9% | — |
| 资本支出强度资本支出/营收 | 20.2% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $54.6M | — |
8季度趋势，按日历期对齐
经营现金流CARERIGL
| Q4 25 | $39.9M | $22.0M | ||
| Q3 25 | $11.8M | $24.0M | ||
| Q2 25 | $9.6M | $30.5M | ||
| Q1 25 | $6.4M | $-893.0K | ||
| Q4 24 | $36.9M | $14.5M | ||
| Q3 24 | $10.3M | $21.7M | ||
| Q2 24 | $-2.5M | $302.0K | ||
| Q1 24 | $17.6M | $-5.0M |
自由现金流CARERIGL
| Q4 25 | $31.8M | — | ||
| Q3 25 | $10.3M | — | ||
| Q2 25 | $7.7M | — | ||
| Q1 25 | $4.9M | — | ||
| Q4 24 | $28.8M | — | ||
| Q3 24 | $8.4M | — | ||
| Q2 24 | $-4.3M | — | ||
| Q1 24 | $16.3M | — |
自由现金流率CARERIGL
| Q4 25 | 79.9% | — | ||
| Q3 25 | 26.3% | — | ||
| Q2 25 | 20.6% | — | ||
| Q1 25 | 13.1% | — | ||
| Q4 24 | 83.5% | — | ||
| Q3 24 | 24.6% | — | ||
| Q2 24 | -12.7% | — | ||
| Q1 24 | 48.8% | — |
资本支出强度CARERIGL
| Q4 25 | 20.2% | — | ||
| Q3 25 | 3.9% | — | ||
| Q2 25 | 5.1% | — | ||
| Q1 25 | 4.1% | — | ||
| Q4 24 | 23.6% | — | ||
| Q3 24 | 5.5% | — | ||
| Q2 24 | 5.4% | — | ||
| Q1 24 | 3.9% | — |
现金转化率CARERIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 2.18× | 0.86× | ||
| Q2 25 | 1.13× | 0.51× | ||
| Q1 25 | 0.71× | -0.08× | ||
| Q4 24 | — | 1.01× | ||
| Q3 24 | 1.83× | 1.75× | ||
| Q2 24 | -0.51× | — | ||
| Q1 24 | 3.03× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
